Truncation of c-Myb is associated with its oncogenic activation and differentially truncated forms of Myb result in the transformation of phenotypically distinct hematopoietic cell types. Thus, structural modifications alter the function of c-Myb. During normal differentiation structural modifications could be mediated by phosphorylation or differential RNA splicing. It is clear the c-Myb is a phosphoprotein and we have recently found that pp42mapk phosphorylates c-Myb in vitro at multiple sites. Interestingly, these sites appear to be located in the negative regulatory domain which has been shown to affect c-Myb sequence specific DNA binding, transcription transactivation, transformation and to potentially be involved in protein/protein interactions. The regulation of transcription factor function by phosphorylation is an attractive hypothesis as it would allow for the integration of a number of signalling pathways via protein kinases and phosphatases at the nuclear level. It is the purpose of this proposal to explore the regulation of c-Myb function by phosphorylation. Thus, this proposal has three specific aims. First, we will use two dimensional phosphopeptide mapping to characterize c-Myb phosphorylation in vivo with particular emphasis on determining conditions under which the pp42mapk sites are phosphorylated. Second, we will use four measures of c-myb activity to determine the role of phosphorylation in regulating c-myb function including: 1) sequence specific DNA binding, 2) transcription transactivation, 3) transformation and 4) the ability to block terminal differentiation in murine erythroleukemia cells. Third, we will identify and functionally characterize novel sites of phosphorylation c-Myb. In our first specific aim we expect to identify changes in sites of phosphorylation aside from the pp42mapk phosphorylation sites. This will allow us to move beyond the pp42mapk sites and begin to understand the impact of other kinases on c-Myb function. The broad goal of this proposal is to understand the role played by phosphorylation in regulating c-Myb function.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA040042-14
Application #
6102233
Study Section
Project Start
Project End
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Walters, Dustin M; Lindberg, James M; Adair, Sara J et al. (2013) Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. Neoplasia 15:143-55
Guerrero, Michael S; Parsons, J Thomas; Bouton, Amy H (2012) Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton. Genes Cancer 3:371-81
Owen, Katherine A; Abshire, Michelle Y; Tilghman, Robert W et al. (2011) FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing. PLoS One 6:e23123
Ohama, Takashi; Brautigan, David L (2010) Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J Biol Chem 285:8711-8
Hall, Emily H; Balsbaugh, Jeremy L; Rose, Kristie L et al. (2010) Comprehensive analysis of phosphorylation sites in Tensin1 reveals regulation by p38MAPK. Mol Cell Proteomics 9:2853-63
Hall, Emily H; Daugherty, Abbi E; Choi, Colin K et al. (2009) Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion. J Biol Chem 284:34713-22
Molhoek, Kerrington R; McSkimming, Chantel C; Olson, Walter C et al. (2009) Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2. Cancer Immunol Immunother 58:867-76
Slack-Davis, Jill K; Hershey, E Daniel; Theodorescu, Dan et al. (2009) Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Ther 8:2470-7
Tilghman, Robert W; Parsons, J Thomas (2008) Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin Cancer Biol 18:45-52
Vomastek, Tomas; Iwanicki, Marcin P; Burack, W Richard et al. (2008) Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction. Mol Cell Biol 28:6954-66

Showing the most recent 10 out of 222 publications